Investigating hookworm genomes by comparative analysis of two Ancylostoma species

Background Hookworms, infecting over one billion people, are the mostly closely related major human parasites to the model nematode Caenorhabditis elegans. Applying genomics techniques to these species, we analyzed 3,840 and 3,149 genes from Ancylostoma caninum and A. ceylanicum. Results Transcripts originated from libraries representing infective L3 larva, stimulated L3, arrested L3, and adults. Most genes are represented in single stages including abundant transcripts like hsp-20 in infective L3 and vit-3 in adults. Over 80% of the genes have homologs in C. elegans, and nearly 30% of these were with observable RNA interference phenotypes. Homologies were identified to nematode-specific and clade V specific gene families. To study the evolution of hookworm genes, 574 A. caninum / A. ceylanicum orthologs were identified, all of which were found to be under purifying selection with distribution ratios of nonsynonymous to synonymous amino acid substitutions similar to that reported for C. elegans / C. briggsae orthologs. The phylogenetic distance between A. caninum and A. ceylanicum is almost identical to that for C. elegans / C. briggsae. Conclusion The genes discovered should substantially accelerate research toward better understanding of the parasites' basic biology as well as new therapies including vaccines and novel anthelmintics

Ivermectin, ‘Wonder drug’ from Japan: the human use perspective

Discovered in the late-1970s, the pioneering drug ivermectin, a dihydro derivative of avermectin—originating solely from a single microorganism isolated at the Kitasato Intitute, Tokyo, Japan from Japanese soil—has had an immeasurably beneficial impact in improving the lives and welfare of billions of people throughout the world. Originally introduced as a veterinary drug, it kills a wide range of internal and external parasites in commercial livestock and companion animals. It was quickly discovered to be ideal in combating two of the world’s most devastating and disfiguring diseases which have plagued the world’s poor throughout the tropics for centuries. It is now being used free-of-charge as the sole tool in campaigns to eliminate both diseases globally. It has also been used to successfully overcome several other human diseases and new uses for it are continually being found. This paper looks in depth at the events surrounding ivermectin’s passage from being a huge success in Animal Health into its widespread use in humans, a development which has led many to describe it as a “wonder” drug

Estimating critical habitat based on year-round movements of the endangered Jefferson salamander (Ambystoma jeffersonianum) and their unisexual dependents

Habitat protection is a key component of endangered species conservation but critical habitat designations are often based on limited data or habitat use during only a portion of a species’ life cycle. Protected habitat around breeding pools for the endangered Jefferson salamander (Ambystoma jeffersonianum (Green, 1827)) and their unisexual dependants (Ambystoma laterale - (2) jeffersonianum) is based upon limited movement data from primarily spring and summer seasons. Furthermore, despite their treatment as distinct species under Canada’s Species at Risk Act, differences in habitat use have not been directly compared in areas where they co-occur. We used radio telemetry to track A. jeffersonianum and A. laterale – jeffersonianum (LJJ and LJJJ) during fall migrations to overwintering sites. We used these data and summarized available movement data from past studies that tracked movements in other periods of the annual cycle to estimate year-round critical habitat. A. jeffersonianum travelled significantly longer distances to overwintering locations than unisexuals. Individuals were more likely to overwinter next to a similar genomotype individual than not. Critical habitat encompassing the entire annual cycle of A. jeffersonianum extends up to 400-450 m from breeding ponds indicating existing regulatory habitat protections in Canada do not currently protect sufficient habitat.The accepted manuscript in pdf format is listed with the files at the bottom of this page. The presentation of the authors' names and (or) special characters in the title of the manuscript may differ slightly between what is listed on this page and what is listed in the pdf file of the accepted manuscript; that in the pdf file of the accepted manuscript is what was submitted by the author